- News Library
- Servier Medical Art
- Partnering & Licensing
From the outset, Dr Jacques Servier wanted to guarantee the sustainability and independence of his Group.
To achieve this, his guiding principle was that entrepreneurial decisions should prevail over expanding his personal assets.
The framework chosen, in the early 1980s, was to ensure that the Group’s management (governance) and ownership of capital (ie, the Group’s assets) were kept separate.
The following points were defined:
The accompanying chart illustrates these points.
The main components of this legal structure are therefore:
Click here to see the organization chart.
It must be underlined that no physical person participates in the capital of the Group, and that the Foundation, which is the organization’s linchpin, is an entity with no share capital, and which therefore is untransferable.
The purpose of this legal structure is to ensure the stability, sustainability, and independence of the Group. Further, it also ensures the Group’s independence from financial markets, which too often favor short-term choices over long-term decisions. Finally, it makes it possible to reinvest 100% of resources in the Group, which has never distributed any dividends.
The decision-making process has been designed to favor achieving a consensus without impeding efficacy of action.
The FIRS Foundation is comprised of the following Bodies:
Its members are also the members of the Executive Committee of Servier SAS:
Click here to see the members of the Executive Committee.
The list of members of the Foundation Council:
The list of members of the Supervisory Board:
Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in 148 countries, with more than 21 200 employees, including close to 3000 in R&D.